Schedule 13G ownership disclosure
ABVC BIOPHARMA INC
Security class unavailable · CUSIP: 00091F106
Event date: 2023-07-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-23-002183
- Form type
- SC 13G
- Filer
- ABVC BIOPHARMA, INC.
- CIK
- CIK 1173313
- Filed
- Aug 07, 2023
- Reporting period
- Jul 28, 2023
- Description
- Schedule 13G beneficial ownership